BofA analyst Farrell Granath raised the firm’s price target on American Healthcare REIT (AHR) to $51 from $49 and keeps a Buy rating on the shares. A “silver tsunami’ in the U.S. is expected to to drive big gains for the major players in the senior housing business as Boomers age into senior living, says the analyst, who forecasts that margins for the five SHOP REITs- Welltower (WELL), Ventas (VTR), Sabra (SBRA), American Healthcare REIT and National Health Investor (NHI) – will expand ahead of Street estimates in 2026.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $50 from $45 at Citizens JMP
- American Healthcare REIT price target raised to $43 from $40 at KeyBanc
- American Healthcare REIT initiated with a Buy at UBS
- Buy Rating for American Healthcare REIT, Inc. Driven by Strong AFFO Growth and Strategic Expansion in Senior Housing
- American Healthcare REIT Announces Quarterly Distribution